3-aryl-4-alkyl and 4,5-dialkyl-4h-1,2,4-triazoles useful as memory enhancers
CA 2175352 C · Owner: Dalton, Christopher Robin · Inventors: Kane, John Michael; Dalton, Christopher Robin; Miller, Jerry Alan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates, to the enhancement of memory and cognition, and the treatment of Alzheimer's disease and, Wernicke-Korsakoff syndrome by administration, of 3-aryl-4-alkyl and 4,5dialkyl-4H-1,2,4-triazoles, of formula (I) wherein R1 and R2 independently represent hydrogen halogen, trifluoromethyl, nitro, C1-4 lower alkyl or C1-4 lower alkoxy or together, R1 and R2, represent -CH=CH-CH=CHforming a 1- or 2-naphthylenyl ring system; R3 represents hydrogen or C1-4 lower alkyl; and R4 represents C1-4 lower alkyl, benzyl, or benzyl substituted by one or two groups selected from halogen trifluoromethyl, nitro, C1-4 lower alkyl or C1-4 lower alkoxy.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 4, 1994 and granted March 2, 1999. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 4, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 4, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.